Several studies have indicated that SARS-CoV-2 specific nasal IgA but not IgG may serve as an indicator for predicting the risk of re-infection and assessing nasal antibody response after a natural infection or nasal vaccination [14, 16, 27, 28]. Here, CD79A is linked to infection.